This proposal is based on an initial assessment of the literature on the safety of low doses of CBD, published by the TGA in April 2020. Epidyolex was approved on September 18, 2020 for additional therapy for seizures associated with Lennox-Gastaut syndrome or Dravet syndrome and was added to ARTG on September 21, 2020 USA […]
